只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-30 2026-07-31 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 644 | US$523.04 | US$336,836.54 | 333,299 | SEC |
| 2026-07-30 2026-07-31 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,486 | US$523.87 | US$778,478.10 | 331,813 | SEC |
| 2026-07-30 2026-07-31 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 4,846 | US$524.88 | US$254.36万 | 326,967 | SEC |
| 2026-07-30 2026-07-31 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 2,084 | US$525.80 | US$109.58万 | 324,883 | SEC |
| 2026-07-30 2026-07-31 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 400 | US$526.92 | US$210,769.20 | 324,483 | SEC |
| 2026-07-30 2026-07-31 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 40 | US$528.96 | US$21,158.40 | 324,443 | SEC |
| 2026-07-30 2026-07-30 | FCBC FIRST COMMUNITY BANKSHARES INC /VA/ | Mills Gary R Officer · President | 卖出（S） | 3,500 | US$47.67 | US$166,848.50 | 5,798 | SEC |
| 2026-07-29 2026-07-30 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 798 | US$518.25 | US$413,564.62 | 333,145 | SEC |
| 2026-07-29 2026-07-30 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,112 | US$519.29 | US$577,453.15 | 332,033 | SEC |
| 2026-07-29 2026-07-30 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 900 | US$520.40 | US$468,363.78 | 331,133 | SEC |
| 2026-07-29 2026-07-30 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,270 | US$521.32 | US$662,077.80 | 329,863 | SEC |
| 2026-07-29 2026-07-30 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 880 | US$522.51 | US$459,813.11 | 328,983 | SEC |
| 2026-07-29 2026-07-30 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,318 | US$523.63 | US$690,137.75 | 327,665 | SEC |
| 2026-07-29 2026-07-30 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,982 | US$524.47 | US$103.95万 | 325,683 | SEC |
| 2026-07-29 2026-07-30 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,240 | US$525.46 | US$651,574.86 | 324,443 | SEC |
| 2026-07-29 2026-07-29 | NECB NorthEast Community Bancorp, Inc./MD/ | Hom Donald S Officer · EVP and CFO | 卖出（S） | 3,000 | US$27.20 | US$81,593.40 | 4,714 | SEC |
| 2026-07-28 2026-07-29 | FUNC FIRST UNITED CORP/MD/ | Fisher Robert L. II Officer · EVP & Chief Banking Officer | 卖出（S） | 5,250 | US$45.29 | US$237,772.50 | 9,105 | SEC |
| 2026-07-28 2026-07-28 | UAL United Airlines Holdings, Inc. | Hart Brett J Officer · President | 卖出（S） | 30,108 | US$120.72 | US$363.46万 | 371,583 | SEC |
| 2026-07-28 2026-07-28 | UAL United Airlines Holdings, Inc. | Nocella Andrew P Officer · EVP & Chief Commercial Officer | 卖出（S） | 4,200 | US$120.48 | US$506,016.00 | 222,955 | SEC |
| 2026-07-28 2026-07-28 | FCCO FIRST COMMUNITY CORP /SC/ | Deutsch Fred Joseph Director,Officer · Executive Vice President | 卖出（S） | 5,000 | US$34.53 | US$172,650.00 | 23,468 | SEC |
| 2026-07-28 2026-07-28 | FCCO FIRST COMMUNITY CORP /SC/ | Deutsch Fred Joseph Director,Officer · Executive Vice President | 卖出（S） | 5,000 | US$34.50 | US$172,500.00 | 18,468 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,367 | US$523.15 | US$715,152.06 | 332,576 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 40 | US$532.49 | US$21,299.58 | 324,443 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,074 | US$524.04 | US$562,817.56 | 331,502 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 876 | US$525.02 | US$459,918.05 | 330,626 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,473 | US$526.34 | US$775,294.70 | 329,153 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,369 | US$527.16 | US$721,677.66 | 327,784 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,149 | US$528.20 | US$606,904.56 | 326,635 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 625 | US$529.41 | US$330,882.38 | 326,010 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,124 | US$530.29 | US$596,047.98 | 324,886 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 403 | US$530.97 | US$213,981.03 | 324,483 | SEC |
| 2026-07-28 2026-07-28 | UCB UNITED COMMUNITY BANKS INC | HARRALSON JEFFERSON L Officer · EVP, CFO | 卖出（S） | 25,000 | US$35.41 | US$885,250.00 | 37,433 | SEC |
| 2026-07-27 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 680 | US$525.81 | US$357,551.55 | 333,263 | SEC |
| 2026-07-27 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 890 | US$527.14 | US$469,152.46 | 332,373 | SEC |
| 2026-07-27 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 650 | US$528.51 | US$343,529.55 | 331,723 | SEC |
| 2026-07-27 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,797 | US$529.75 | US$951,959.49 | 329,926 | SEC |
| 2026-07-27 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,121 | US$530.49 | US$594,674.92 | 328,805 | SEC |
| 2026-07-27 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,836 | US$531.65 | US$976,107.20 | 326,969 | SEC |
| 2026-07-27 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,529 | US$532.38 | US$814,004.43 | 325,440 | SEC |
| 2026-07-27 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 957 | US$533.53 | US$510,589.55 | 324,483 | SEC |
| 2026-07-27 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 40 | US$535.04 | US$21,401.60 | 324,443 | SEC |
| 2026-07-27 2026-07-27 | UCB UNITED COMMUNITY BANKS INC | BRADSHAW RICHARD Officer · EVP, Chief Banking Officer | 卖出（S） | 1,422 | US$35.09 | US$49,897.98 | 83,230 | SEC |
| 2026-07-27 2026-07-27 | UCB UNITED COMMUNITY BANKS INC | BRADSHAW RICHARD Officer · EVP, Chief Banking Officer | 卖出（S） | 2 | US$35.15 | US$70.30 | 83,228 | SEC |
| 2026-07-24 2026-07-28 | NMZ NUVEEN MUNICIPAL HIGH INCOME OPPORTUNITY FUND | BANK OF AMERICA CORP /DE/ TenPercentOwner | 买入（P） | 9 | US$10.24 | US$92.12 | 9 | SEC |
| 2026-07-24 2026-07-28 | NMZ NUVEEN MUNICIPAL HIGH INCOME OPPORTUNITY FUND | MERRILL LYNCH, PIERCE, FENNER & SMITH INC. TenPercentOwner | 买入（P） | 9 | US$10.24 | US$92.12 | 9 | SEC |
| 2026-07-24 2026-07-28 | NMZ NUVEEN MUNICIPAL HIGH INCOME OPPORTUNITY FUND | BANK OF AMERICA CORP /DE/ TenPercentOwner | 卖出（S） | 9 | US$10.18 | US$91.58 | 0 | SEC |
| 2026-07-24 2026-07-28 | NMZ NUVEEN MUNICIPAL HIGH INCOME OPPORTUNITY FUND | MERRILL LYNCH, PIERCE, FENNER & SMITH INC. TenPercentOwner | 卖出（S） | 9 | US$10.18 | US$91.58 | 0 | SEC |
| 2026-07-24 2026-07-28 | UAL United Airlines Holdings, Inc. | Enqvist Torbjorn J Officer · EVP & Chief Operations Officer | 卖出（S） | 20,000 | US$119.91 | US$239.82万 | 114,800 | SEC |
| 2026-07-24 2026-07-28 | FUNC FIRST UNITED CORP/MD/ | RUDY IRVIN ROBERT Director | 卖出（S） | 1,000 | US$44.58 | US$44,580.00 | 37,500 | SEC |
| 2026-07-24 2026-07-27 | PEBO PEOPLES BANCORP INC | Donlon Hugh J Officer · EVP, Community Banking | 卖出（S） | 500 | US$39.87 | US$19,935.00 | 23,365.2266 | SEC |
| 2026-07-24 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 820 | US$528.72 | US$433,548.76 | 333,123 | SEC |
| 2026-07-24 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 2,285 | US$530.45 | US$121.21万 | 330,838 | SEC |
| 2026-07-24 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,115 | US$531.10 | US$592,178.84 | 329,723 | SEC |
| 2026-07-24 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 2,719 | US$532.27 | US$144.72万 | 327,004 | SEC |
| 2026-07-24 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,818 | US$533.20 | US$969,355.96 | 325,186 | SEC |
| 2026-07-24 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 630 | US$534.39 | US$336,668.09 | 324,556 | SEC |
| 2026-07-24 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 113 | US$535.03 | US$60,457.89 | 324,443 | SEC |
| 2026-07-24 2026-07-24 | URI UNITED RENTALS, INC. | Grace William E. Officer · EVP, CFO | 卖出（S） | 1,500 | US$1,133.15 | US$169.97万 | 6,061.653 | SEC |
| 2026-07-23 2026-07-27 | FUNC FIRST UNITED CORP/MD/ | Sanders Keith Officer · EVP & Chief Wealth Officer | 卖出（S） | 5,000 | US$43.68 | US$218,397.50 | 10,341.8195 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 249 | US$522.87 | US$130,194.85 | 333,694 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 200 | US$531.83 | US$106,366.80 | 324,443 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 339 | US$523.72 | US$177,539.72 | 333,355 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 171 | US$524.86 | US$89,751.18 | 333,184 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 387 | US$525.83 | US$203,496.79 | 332,797 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 552 | US$526.88 | US$290,835.39 | 332,245 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,989 | US$527.77 | US$104.97万 | 330,256 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 2,133 | US$529.08 | US$112.85万 | 328,123 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 2,279 | US$529.86 | US$120.75万 | 325,844 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,201 | US$530.84 | US$637,540.16 | 324,643 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 120 | US$524.27 | US$62,912.40 | 333,823 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 107 | US$535.40 | US$57,288.07 | 326,563 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 790 | US$536.49 | US$423,826.63 | 325,773 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 570 | US$537.60 | US$306,433.94 | 325,203 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 680 | US$538.46 | US$366,153.00 | 324,523 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 80 | US$539.47 | US$43,157.60 | 324,443 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 485 | US$526.04 | US$255,130.95 | 333,338 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 2,610 | US$526.84 | US$137.51万 | 330,728 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,211 | US$527.82 | US$639,188.81 | 329,517 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 874 | US$528.91 | US$462,264.89 | 328,643 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 760 | US$529.80 | US$402,644.50 | 327,883 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 400 | US$531.22 | US$212,489.80 | 327,483 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 489 | US$533.24 | US$260,755.53 | 326,994 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 324 | US$534.19 | US$173,075.94 | 326,670 | SEC |
| 2026-07-22 2026-07-22 | BTO JOHN HANCOCK FINANCIAL OPPORTUNITIES FUND | Bacic William K Other | 买入（P） | 184 | US$40.62 | US$7,474.08 | 472 | SEC |
| 2026-07-21 2026-07-22 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 120 | US$524.37 | US$62,923.97 | 333,823 | SEC |
| 2026-07-21 2026-07-22 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 341 | US$535.44 | US$182,585.72 | 325,282 | SEC |
| 2026-07-21 2026-07-22 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 839 | US$536.37 | US$450,017.95 | 324,443 | SEC |
| 2026-07-21 2026-07-22 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 160 | US$526.24 | US$84,198.00 | 333,663 | SEC |
| 2026-07-21 2026-07-22 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 240 | US$527.46 | US$126,590.40 | 333,423 | SEC |
| 2026-07-21 2026-07-22 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 509 | US$529.55 | US$269,541.31 | 332,914 | SEC |
| 2026-07-21 2026-07-22 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,926 | US$530.50 | US$102.17万 | 330,988 | SEC |
| 2026-07-21 2026-07-22 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 2,605 | US$531.52 | US$138.46万 | 328,383 | SEC |
| 2026-07-21 2026-07-22 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 360 | US$532.47 | US$191,688.41 | 328,023 | SEC |
| 2026-07-21 2026-07-22 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 640 | US$533.58 | US$341,489.79 | 327,383 | SEC |
| 2026-07-21 2026-07-22 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,760 | US$534.61 | US$940,922.05 | 325,623 | SEC |
| 2026-07-21 2026-07-21 | UAL United Airlines Holdings, Inc. | KIRBY J SCOTT Director,Officer · Chief Executive Officer | 卖出（S） | 159,321 | US$118.05 | US$1880.7万 | 797,851 | SEC |
| 2026-07-20 2026-07-21 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,831 | US$529.19 | US$968,944.51 | 332,112 | SEC |
| 2026-07-20 2026-07-21 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 960 | US$529.85 | US$508,656.86 | 331,152 | SEC |
| 2026-07-20 2026-07-21 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,660 | US$531.08 | US$881,587.99 | 329,492 | SEC |
| 2026-07-20 2026-07-21 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,874 | US$532.07 | US$997,104.61 | 327,618 | SEC |
| 2026-07-20 2026-07-21 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,686 | US$533.03 | US$898,683.18 | 325,932 | SEC |
| 2026-07-20 2026-07-21 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 889 | US$534.13 | US$474,838.37 | 325,043 | SEC |
| 2026-07-20 2026-07-21 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 520 | US$535.20 | US$278,306.29 | 324,523 | SEC |
| 2026-07-20 2026-07-21 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 80 | US$536.41 | US$42,912.80 | 324,443 | SEC |
| 2026-07-17 2026-07-20 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 240 | US$528.91 | US$126,938.40 | 333,703 | SEC |
| 2026-07-17 2026-07-20 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 892 | US$542.06 | US$483,520.55 | 324,736 | SEC |
| 2026-07-17 2026-07-20 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 293 | US$542.43 | US$158,932.25 | 324,443 | SEC |
| 2026-07-17 2026-07-20 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 240 | US$530.83 | US$127,399.99 | 333,463 | SEC |
| 2026-07-17 2026-07-20 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 720 | US$534.57 | US$384,889.03 | 332,743 | SEC |
| 2026-07-17 2026-07-20 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 2,350 | US$535.53 | US$125.85万 | 330,393 | SEC |
| 2026-07-17 2026-07-20 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 2,110 | US$536.36 | US$113.17万 | 328,283 | SEC |
| 2026-07-17 2026-07-20 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,160 | US$537.45 | US$623,438.06 | 327,123 | SEC |
| 2026-07-17 2026-07-20 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 423 | US$538.70 | US$227,871.20 | 326,700 | SEC |
| 2026-07-17 2026-07-20 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 821 | US$539.63 | US$443,033.44 | 325,879 | SEC |
| 2026-07-17 2026-07-20 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 251 | US$540.69 | US$135,713.82 | 325,628 | SEC |
| 2026-07-16 2026-07-20 | THQ abrdn Healthcare Opportunities Fund | Mahai Chris LaVictoire Director | 买入（P） | 568 | US$18.49 | US$10,502.32 | 568 | SEC |
| 2026-07-16 2026-07-17 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 80 | US$527.31 | US$42,185.08 | 333,863 | SEC |
| 2026-07-16 2026-07-17 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 11 | US$537.11 | US$5,908.21 | 324,443 | SEC |
| 2026-07-16 2026-07-17 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,400 | US$528.42 | US$739,782.96 | 332,463 | SEC |
| 2026-07-16 2026-07-17 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 3,057 | US$529.46 | US$161.86万 | 329,406 | SEC |
| 2026-07-16 2026-07-17 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,924 | US$530.14 | US$102万 | 327,482 | SEC |
| 2026-07-16 2026-07-17 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 520 | US$532.14 | US$276,711.50 | 326,962 | SEC |
| 2026-07-16 2026-07-17 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 440 | US$533.28 | US$234,644.39 | 326,522 | SEC |
| 2026-07-16 2026-07-17 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,198 | US$534.31 | US$640,100.62 | 325,324 | SEC |
| 2026-07-16 2026-07-17 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 720 | US$535.20 | US$385,342.42 | 324,604 | SEC |
| 2026-07-16 2026-07-17 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 150 | US$536.29 | US$80,443.07 | 324,454 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 19 | US$1.55 | US$29.45 | 743,057 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 19 | US$1.55 | US$29.45 | 743,057 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 19 | US$1.55 | US$29.45 | 743,057 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 19 | US$1.55 | US$29.45 | 743,057 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 2 | US$1.55 | US$3.10 | 75,019 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 2 | US$1.55 | US$3.10 | 75,019 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 2 | US$1.55 | US$3.10 | 75,019 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 2 | US$1.55 | US$3.10 | 75,019 | SEC |
| 2026-07-16 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | MAHON PAUL A Officer · EVP & GENERAL COUNSEL | 卖出（S） | 600 | US$527.60 | US$316,557.00 | 52,872 | SEC |
| 2026-07-16 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | MAHON PAUL A Officer · EVP & GENERAL COUNSEL | 卖出（S） | 120 | US$529.81 | US$63,577.20 | 52,752 | SEC |
| 2026-07-16 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | MAHON PAUL A Officer · EVP & GENERAL COUNSEL | 卖出（S） | 861 | US$531.97 | US$458,025.48 | 51,891 | SEC |
| 2026-07-16 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | MAHON PAUL A Officer · EVP & GENERAL COUNSEL | 卖出（S） | 800 | US$532.94 | US$426,351.52 | 51,091 | SEC |
| 2026-07-16 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | MAHON PAUL A Officer · EVP & GENERAL COUNSEL | 卖出（S） | 3,279 | US$534.21 | US$175.17万 | 47,812 | SEC |
| 2026-07-16 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | MAHON PAUL A Officer · EVP & GENERAL COUNSEL | 卖出（S） | 1,041 | US$535.88 | US$557,850.87 | 46,771 | SEC |
| 2026-07-16 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | MAHON PAUL A Officer · EVP & GENERAL COUNSEL | 卖出（S） | 1,519 | US$534.99 | US$812,648.44 | 45,252 | SEC |
| 2026-07-16 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | MAHON PAUL A Officer · EVP & GENERAL COUNSEL | 卖出（S） | 80 | US$536.85 | US$42,948.21 | 45,172 | SEC |
| 2026-07-15 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 80 | US$521.82 | US$41,745.60 | 42,151 | SEC |
| 2026-07-15 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 48 | US$520.92 | US$25,003.96 | 332,177 | SEC |
| 2026-07-15 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 189 | US$521.84 | US$98,627.91 | 331,988 | SEC |
| 2026-07-15 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 203 | US$523.20 | US$106,210.09 | 331,785 | SEC |
| 2026-07-15 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 440 | US$524.40 | US$230,734.02 | 331,345 | SEC |
| 2026-07-15 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 280 | US$525.24 | US$147,066.39 | 331,065 | SEC |
| 2026-07-15 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 120 | US$527.77 | US$63,332.40 | 330,945 | SEC |
| 2026-07-15 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 641 | US$529.03 | US$339,105.67 | 330,304 | SEC |
| 2026-07-15 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 577 | US$530.12 | US$305,878.37 | 329,727 | SEC |
| 2026-07-15 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,044 | US$531.03 | US$554,390.62 | 328,683 | SEC |
| 2026-07-15 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 120 | US$523.97 | US$62,876.80 | 42,031 | SEC |
| 2026-07-15 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 3,295 | US$531.97 | US$175.28万 | 325,388 | SEC |
| 2026-07-15 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 825 | US$533.08 | US$439,790.75 | 324,563 | SEC |
| 2026-07-15 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 120 | US$534.27 | US$64,112.80 | 324,443 | SEC |
| 2026-07-15 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 80 | US$525.43 | US$42,034.00 | 41,951 | SEC |
| 2026-07-15 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 40 | US$527.55 | US$21,102.00 | 41,911 | SEC |
| 2026-07-15 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 120 | US$529.66 | US$63,559.60 | 41,791 | SEC |
| 2026-07-15 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 278 | US$530.97 | US$147,609.05 | 41,513 | SEC |
| 2026-07-15 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 800 | US$532.06 | US$425,647.44 | 40,713 | SEC |
| 2026-07-15 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 160 | US$533.22 | US$85,314.80 | 40,553 | SEC |
| 2026-07-15 2026-07-16 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 40 | US$534.09 | US$21,363.60 | 40,513 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 13,761 | US$1.55 | US$21,329.55 | 743,038 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 13,761 | US$1.55 | US$21,329.55 | 743,038 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 13,761 | US$1.55 | US$21,329.55 | 743,038 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 13,761 | US$1.55 | US$21,329.55 | 743,038 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 1,389 | US$1.55 | US$2,152.95 | 75,017 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 1,389 | US$1.55 | US$2,152.95 | 75,017 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 1,389 | US$1.55 | US$2,152.95 | 75,017 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 1,389 | US$1.55 | US$2,152.95 | 75,017 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 4,882 | US$1.55 | US$7,567.10 | 729,277 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 4,882 | US$1.55 | US$7,567.10 | 729,277 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 4,882 | US$1.55 | US$7,567.10 | 729,277 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 4,882 | US$1.55 | US$7,567.10 | 729,277 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 493 | US$1.55 | US$764.15 | 73,628 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 493 | US$1.55 | US$764.15 | 73,628 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 493 | US$1.55 | US$764.15 | 73,628 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 493 | US$1.55 | US$764.15 | 73,628 | SEC |
| 2026-07-14 2026-07-15 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 840 | US$524.15 | US$440,283.56 | 49,173 | SEC |
| 2026-07-14 2026-07-15 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,468 | US$525.16 | US$770,940.46 | 47,705 | SEC |
| 2026-07-14 2026-07-15 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 3,492 | US$526.13 | US$183.73万 | 44,213 | SEC |
| 2026-07-14 2026-07-15 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,220 | US$527.06 | US$643,009.91 | 42,993 | SEC |
| 2026-07-14 2026-07-15 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 660 | US$528.13 | US$348,568.51 | 42,333 | SEC |
| 2026-07-14 2026-07-15 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 959 | US$529.21 | US$507,512.20 | 41,374 | SEC |
| 2026-07-14 2026-07-15 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 554 | US$530.67 | US$293,992.62 | 40,820 | SEC |
| 2026-07-14 2026-07-15 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 107 | US$531.08 | US$56,825.68 | 40,713 | SEC |
| 2026-07-14 2026-07-15 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 200 | US$532.60 | US$106,520.40 | 40,513 | SEC |
| 2026-07-13 2026-07-15 | USEA United Maritime Corp | Gyftakis Stavros Director,Officer · See Remarks | 卖出（S） | 5,000 | US$2.64 | US$13,200.00 | 246,678 | SEC |
| 2026-07-13 2026-07-14 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,020 | US$533.70 | US$544,376.24 | 48,993 | SEC |
| 2026-07-13 2026-07-14 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 2,272 | US$534.63 | US$121.47万 | 46,721 | SEC |
| 2026-07-13 2026-07-14 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 2,191 | US$535.47 | US$117.32万 | 44,530 | SEC |
| 2026-07-13 2026-07-14 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 2,223 | US$536.52 | US$119.27万 | 42,307 | SEC |
| 2026-07-13 2026-07-14 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 665 | US$537.66 | US$357,545.36 | 41,642 | SEC |
| 2026-07-13 2026-07-14 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 409 | US$538.60 | US$220,289.32 | 41,233 | SEC |
| 2026-07-13 2026-07-14 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 320 | US$539.60 | US$172,673.41 | 40,913 | SEC |
| 2026-07-13 2026-07-14 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 360 | US$541.10 | US$194,795.89 | 40,553 | SEC |
| 2026-07-13 2026-07-14 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 40 | US$542.80 | US$21,712.00 | 40,513 | SEC |
| 2026-07-13 2026-07-13 | UMC UNITED MICROELECTRONICS CORP | Liu Chitung Officer · CFO & SVP | 卖出（S） | 1,900,000 | US$154.89 | US$2.94亿 | 3,322,917 | SEC |
| 2026-07-10 2026-07-13 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 600 | US$540.37 | US$324,222.66 | 49,413 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| UNIT | 786,771.2966 | 11,773 | 1,048,890.1473 | 75.01% | B, Q, N |